查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1758788

GABA補充劑的全球市場

GABA Supplements
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 279 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計到 2030 年全球 GABA 補充劑市場規模將達到 6,080 萬美元

全球GABA補充劑市場規模預計在2024年為4,550萬美元，預計到2030年將達到6,080萬美元，2024年至2030年的複合年成長率為4.9%。膠囊是本報告分析的細分市場之一，預計其複合年成長率為5.4%，到分析期結束時市場規模將達到2950萬美元。錠劑細分市場在分析期間的複合年成長率預計為5.5%。

美國市場規模估計為 1,240 萬美元，中國市場預計複合年成長率為 9.0%

美國GABA 補充劑市場規模預計在 2024 年達到 1,240 萬美元。作為世界第二大經濟體，中國市場規模預計在 2030 年達到 1,280 萬美元，2024 年至 2030 年的複合年成長率為 9.0%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間的複合年成長率分別為 2.0% 和 3.9%。在歐洲，預計德國的複合年成長率為 2.9%。

全球「GABA 補充劑」市場—主要趨勢和促進因素摘要

「GABA 補充劑」在注重健康的消費者中越來越受歡迎的原因是什麼？

近年來，隨著消費者對心理健康、壓力管理和整體健康意識的不斷增強，γ-氨基丁酸 (GABA) 補充劑的吸引力日益增強。 GABA 最初由臨床神經科學界理解，作為一種天然存在的神經傳導物質，如今已成為主流的健康術語。作為一種中樞神經系統抑制劑，GABA 可以促進放鬆並降低神經元興奮性，這通常與改善睡眠品質、減輕焦慮和平衡情緒有關。對非藥物干預的壓力和失眠的需求激增，使 GABA 補充劑成為人們關注的焦點，尤其是在北美和歐洲。千禧世代和 Z 世代正在轉向 GABA 等適應原和情緒增強劑，以增強他們在高壓力環境和社交媒體影響下的情緒恢復能力。同時，電商平台和健康達人正在透過透明的標籤和臨床檢驗進一步提高產品知名度，並建立消費者信任。隨著人們對心理健康的認知逐漸降低，對安全、非處方心理健康產品的需求持續穩定成長。

為什麼會出現配方和交付模式的創新？

隨著配方和給藥方式的創新，GABA 補充劑市場正在重塑，為製造商和消費者創造新的價值提案。從傳統的膠囊和錠劑轉向方便用戶使用的形式，包括軟糖、發泡粉和舌下噴霧劑，這提高了依從性，並吸引了更廣泛的人群。各大品牌還將 GABA 與 L-茶氨酸、鎂、褪黑激素和 5-HTP 等互補成分相結合，以創建旨在整體緩解壓力和改善睡眠的協同混合物。純素、無麩質和非基因改造配方的流行反映了消費者尋求潔淨標示產品的更廣泛趨勢。微膠囊化和奈米遞送系統等技術進步正被用於提高生物利用度和穩定性，解決人們對 GABA血腦障壁滲透性的長期擔憂。此外，自有品牌和名人支持品牌的擴張正在透過推出美觀且注重生活方式的產品來顛覆傳統的補充劑等級制度。這種創新不再局限於藥局和保健品商店，而是透過線上保健精品店和訂閱模式成為主流。

哪些人口統計和分銷管道將推動市場發展？

GABA 補充劑的消費不再局限於注重健康的小眾群體，而是滲透到了各個年齡層和生活方式的人群中。由於學業和職場壓力不斷增加，年輕的專業和學生仍然是主要使用者，但老年人也對 GABA 表現出興趣，因為它有助於睡眠，並在認知健康方面發揮潛在作用。以女性為中心的健康品牌在女性群體中獲得了強力的支持，其針對性配方可以解決與經前症候群相關的情緒波動和更年期壓力。從地區來看，北美佔據領先市場佔有率，而亞太地區的採用率則激增，尤其是在日本、南美和印度的都市區。雖然藥局、保健食品店和專業營養品商店仍然是重要的分銷管道，但在以健康為重點的內容行銷和網紅代言的推動下，電子商務的爆炸式成長正在樹立新的標竿。數位平台透過人工智慧建議提高了產品知名度、直接面對消費者的互動和客製化，重塑了消費者探索和購買 GABA 補充劑的方式。

有幾個因素推動了 GABA 補充劑市場的成長。

GABA 補充劑市場的成長受到多種因素的推動，包括不斷變化的消費者健康優先事項、產品創新以及數位零售轉型。主要促進因素之一是全球焦慮、失眠和壓力相關疾病的增多，這推動了對安全天然情緒穩定劑的需求。其次，膳食補充劑作為合法健康干預措施的接受度日益提高（尤其是在法律規範健全的地區），這提振了消費者信心和零售商庫存。第三，融合健身、正念和補充劑的混合健康方案的興起，為 GABA 產品創造了肥沃的土壤。此外，透過口味創新、針對特定年齡的配方和個人化演算法實現的產品多樣化，正在吸引新的消費群體。醫療保健支出和可支配收入的增加也支撐了市場成長，尤其是在重視預防性保健的新興國家。此外，支持 GABA 補充劑功效的臨床研究正在鼓勵從業者和消費者將這些產品納入他們的日常生活中，從而維持長期需求。

部分

劑型（膠囊、錠劑、粉劑、軟糖）；分銷通路（網路通路、藥局分銷通路、超級市場/大賣場、其他通路）

受訪公司範例（值得關注的36家公司）

  • Amazing Nutrition
  • Aurobindo Pharma
  • Bloomage Biotech
  • Bluebonnet Nutrition
  • Country Life
  • Doctor's Best
  • Douglas Laboratories
  • Enzymatic Therapy
  • Garden of Life
  • Guangdong Luckerkong Biotech
  • Horbaach
  • Integrative Therapeutics
  • Jarrow Formulas
  • Klaire Labs
  • Kyowa Hakko
  • Life Extension
  • Natrol
  • Nature's Truth
  • NOW Foods
  • NutraBio

人工智慧整合

我們正在利用可操作的專家內容和人工智慧工具來改變市場和競爭情報。

Global 特定產業SLM 的典型規範，而是建立了一個從全球專家收集的內容庫，其中包括視訊錄影、部落格、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地、進出口狀況（成品和原始OEM）預測其競爭態勢的變化。這種複雜且多面向的市場動態預計將以多種方式影響競爭對手，包括銷貨成本成本 (COGS) 上升、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

  • 市場概覽
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 競賽

簡介目錄
Product Code: MCP36968

Global GABA Supplements Market to Reach US$60.8 Million by 2030

The global market for GABA Supplements estimated at US$45.5 Million in the year 2024, is expected to reach US$60.8 Million by 2030, growing at a CAGR of 4.9% over the analysis period 2024-2030. Capsules Form, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$29.5 Million by the end of the analysis period. Growth in the Lozenges Form segment is estimated at 5.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$12.4 Million While China is Forecast to Grow at 9.0% CAGR

The GABA Supplements market in the U.S. is estimated at US$12.4 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$12.8 Million by the year 2030 trailing a CAGR of 9.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.0% and 3.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.9% CAGR.

Global "GABA Supplements" Market - Key Trends & Drivers Summarized

What Fuels the Rising Popularity of GABA Supplements Among Health-Conscious Consumers?

Gamma-Aminobutyric Acid (GABA) supplements have gained immense traction in recent years as consumer awareness around mental health, stress management, and holistic well-being continues to surge. Originally understood in clinical neuroscience circles, GABA's role as a naturally occurring neurotransmitter has now entered mainstream wellness vocabulary. As a central nervous system depressant, GABA promotes relaxation, reduces neuronal excitability, and is commonly associated with improved sleep quality, reduced anxiety, and emotional balance. A burgeoning demand for non-pharmaceutical interventions for stress and insomnia has catapulted GABA supplements into the limelight, particularly in North America and Europe. Millennials and Gen Z, driven by high-stress environments and social media influence, are turning to adaptogens and mood enhancers such as GABA to support emotional resilience. Meanwhile, e-commerce platforms and wellness influencers have further amplified product visibility, fostering consumer trust through transparent labeling and clinical validation. As mental health becomes destigmatized, the demand for safe, over-the-counter mental wellness products continues its steady rise.

Why Are Innovations in Formulations and Delivery Formats Gaining Ground?

The GABA supplements market is being reshaped by innovation in formulations and delivery methods, creating new value propositions for manufacturers and consumers alike. From conventional capsules and tablets to gummies, effervescent powders, and sublingual sprays, the shift toward user-friendly formats is enhancing adherence and widening demographic appeal. Brands are also infusing GABA with complementary ingredients such as L-theanine, magnesium, melatonin, and 5-HTP, thereby creating synergistic blends aimed at holistic stress and sleep solutions. The popularity of vegan, gluten-free, and non-GMO formulations reflects a broader consumer trend toward clean-label products. Technological advancements such as microencapsulation and nano-delivery systems are being leveraged to increase bioavailability and stability, addressing the long-standing concern about GABA’s blood-brain barrier permeability. Additionally, private-label expansion and celebrity-backed brands are disrupting traditional supplement hierarchies by introducing high-aesthetic, lifestyle-focused offerings. These innovations are no longer limited to pharmacies and health stores but are now mainstreamed via online wellness boutiques and subscription models.

Which Demographics and Distribution Channels Are Driving Market Evolution?

GABA supplement consumption is no longer confined to niche health-focused groups but is witnessing uptake across a broad spectrum of age groups and lifestyles. While young professionals and students are primary users due to heightened academic and workplace stress, seniors are also showing increased interest in GABA for its sleep-support benefits and potential role in cognitive health. Women-centric wellness brands are crafting targeted formulations addressing PMS-related mood swings and menopausal stress, creating strong traction in female demographic segments. Geographically, while North America leads in terms of market share, Asia-Pacific is witnessing a sharp uptick in adoption, particularly in urban centers of Japan, South Korea, and India. Pharmacies, health and wellness stores, and specialty nutrition outlets remain important distribution channels; however, the explosive growth of e-commerce-powered by wellness-focused content marketing and influencer endorsements-is setting new benchmarks. Digital platforms offer greater product visibility, direct consumer engagement, and customization through AI-powered recommendations, reshaping how consumers explore and purchase GABA supplements.

The Growth in the GABA Supplements Market Is Driven by Several Factors…

The growth in the GABA supplements market is driven by several factors including evolving consumer health priorities, product innovation, and digital retail transformation. One key driver is the global uptick in anxiety, insomnia, and stress-related disorders, which has heightened demand for safe, natural mood stabilizers. Second, the increasing acceptance of nutraceuticals as a legitimate health intervention-particularly in regions with robust regulatory frameworks-is boosting both consumer confidence and retailer inventory. Third, the rise of hybrid wellness routines that combine fitness, mindfulness, and supplementation is creating a fertile ground for GABA products. Further, product diversification through flavor innovation, age-specific formulations, and personalization algorithms is attracting new consumer segments. Market growth is also supported by increasing healthcare expenditure and rising disposable incomes, especially in emerging economies where preventive wellness is gaining importance. Additionally, clinical research supporting the efficacy of GABA supplements is encouraging both practitioners and consumers to integrate these products into daily regimens, sustaining long-term demand.

SCOPE OF STUDY:

The report analyzes the GABA Supplements market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Form (Capsules Form, Lozenges Form, Powder Form, Gummies Form); Distribution Channel (Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets, Other Distribution Channels)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 36 Featured) -

  • Amazing Nutrition
  • Aurobindo Pharma
  • Bloomage Biotech
  • Bluebonnet Nutrition
  • Country Life
  • Doctor's Best
  • Douglas Laboratories
  • Enzymatic Therapy
  • Garden of Life
  • Guangdong Luckerkong Biotech
  • Horbaach
  • Integrative Therapeutics
  • Jarrow Formulas
  • Klaire Labs
  • Kyowa Hakko
  • Life Extension
  • Natrol
  • Nature's Truth
  • NOW Foods
  • NutraBio

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • GABA Supplements - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growing Prevalence of Stress and Anxiety Disorders Spurs Demand for GABA-Based Supplements
    • Consumer Shift Toward Natural Mood Enhancers Strengthens Market for Non-Prescription Solutions
    • Rising Interest in Cognitive Wellness Expands the Addressable Market for Neuroactive Compounds
    • Product Innovation in Gummies and Functional Beverages Drives Adoption of GABA Ingredients
    • E-commerce Growth and DTC Health Brands Accelerate Access to GABA Formulations
    • Clean Label and Plant-Derived Trends Throw Spotlight on Naturally Sourced GABA Supplements
    • Regulatory Flexibility in Nutraceutical Labeling Encourages New Product Launches
    • Increased Scientific Validation of GABAs Effects Strengthens Consumer Confidence and Repeat Usage
    • Rising Popularity of Sleep Aids and Relaxation Products Propels Nighttime GABA Supplement Demand
    • Celebrity and Influencer Endorsements Amplify Market Visibility and Product Differentiation
    • Integrative Health Practices Expand Use of GABA in Holistic Wellness Programs
    • Stacking with Nootropic Formulations Generates Demand for Multi-Ingredient GABA Products
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World GABA Supplements Market Analysis of Annual Sales in US$ for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for GABA Supplements by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for GABA Supplements by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for GABA Supplements by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Capsules Form by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Capsules Form by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for Capsules Form by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Lozenges Form by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Lozenges Form by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Lozenges Form by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Powder Form by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Powder Form by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for Powder Form by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Gummies Form by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Gummies Form by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 16: World 16-Year Perspective for Gummies Form by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Online Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Online Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 19: World 16-Year Perspective for Online Distribution Channel by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Pharmacies Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Pharmacies Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 22: World 16-Year Perspective for Pharmacies Distribution Channel by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Supermarkets / Hypermarkets by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Supermarkets / Hypermarkets by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 25: World 16-Year Perspective for Supermarkets / Hypermarkets by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Other Distribution Channels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Other Distribution Channels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 28: World 16-Year Perspective for Other Distribution Channels by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • GABA Supplements Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 31: USA 16-Year Perspective for GABA Supplements by Form - Percentage Breakdown of Value Sales for Capsules Form, Lozenges Form, Powder Form and Gummies Form for the Years 2014, 2025 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 34: USA 16-Year Perspective for GABA Supplements by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 35: Canada Recent Past, Current & Future Analysis for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 37: Canada 16-Year Perspective for GABA Supplements by Form - Percentage Breakdown of Value Sales for Capsules Form, Lozenges Form, Powder Form and Gummies Form for the Years 2014, 2025 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 40: Canada 16-Year Perspective for GABA Supplements by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels for the Years 2014, 2025 & 2030
  • JAPAN
    • GABA Supplements Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 41: Japan Recent Past, Current & Future Analysis for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 43: Japan 16-Year Perspective for GABA Supplements by Form - Percentage Breakdown of Value Sales for Capsules Form, Lozenges Form, Powder Form and Gummies Form for the Years 2014, 2025 & 2030
    • TABLE 44: Japan Recent Past, Current & Future Analysis for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 46: Japan 16-Year Perspective for GABA Supplements by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels for the Years 2014, 2025 & 2030
  • CHINA
    • GABA Supplements Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 47: China Recent Past, Current & Future Analysis for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 48: China Historic Review for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 49: China 16-Year Perspective for GABA Supplements by Form - Percentage Breakdown of Value Sales for Capsules Form, Lozenges Form, Powder Form and Gummies Form for the Years 2014, 2025 & 2030
    • TABLE 50: China Recent Past, Current & Future Analysis for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 51: China Historic Review for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 52: China 16-Year Perspective for GABA Supplements by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels for the Years 2014, 2025 & 2030
  • EUROPE
    • GABA Supplements Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 53: Europe Recent Past, Current & Future Analysis for GABA Supplements by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for GABA Supplements by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for GABA Supplements by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 58: Europe 16-Year Perspective for GABA Supplements by Form - Percentage Breakdown of Value Sales for Capsules Form, Lozenges Form, Powder Form and Gummies Form for the Years 2014, 2025 & 2030
    • TABLE 59: Europe Recent Past, Current & Future Analysis for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 61: Europe 16-Year Perspective for GABA Supplements by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels for the Years 2014, 2025 & 2030
  • FRANCE
    • GABA Supplements Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 62: France Recent Past, Current & Future Analysis for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France Historic Review for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 64: France 16-Year Perspective for GABA Supplements by Form - Percentage Breakdown of Value Sales for Capsules Form, Lozenges Form, Powder Form and Gummies Form for the Years 2014, 2025 & 2030
    • TABLE 65: France Recent Past, Current & Future Analysis for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 66: France Historic Review for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 67: France 16-Year Perspective for GABA Supplements by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels for the Years 2014, 2025 & 2030
  • GERMANY
    • GABA Supplements Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 68: Germany Recent Past, Current & Future Analysis for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 70: Germany 16-Year Perspective for GABA Supplements by Form - Percentage Breakdown of Value Sales for Capsules Form, Lozenges Form, Powder Form and Gummies Form for the Years 2014, 2025 & 2030
    • TABLE 71: Germany Recent Past, Current & Future Analysis for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Germany Historic Review for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 73: Germany 16-Year Perspective for GABA Supplements by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 74: Italy Recent Past, Current & Future Analysis for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 76: Italy 16-Year Perspective for GABA Supplements by Form - Percentage Breakdown of Value Sales for Capsules Form, Lozenges Form, Powder Form and Gummies Form for the Years 2014, 2025 & 2030
    • TABLE 77: Italy Recent Past, Current & Future Analysis for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Italy Historic Review for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 79: Italy 16-Year Perspective for GABA Supplements by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • GABA Supplements Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 80: UK Recent Past, Current & Future Analysis for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 82: UK 16-Year Perspective for GABA Supplements by Form - Percentage Breakdown of Value Sales for Capsules Form, Lozenges Form, Powder Form and Gummies Form for the Years 2014, 2025 & 2030
    • TABLE 83: UK Recent Past, Current & Future Analysis for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 84: UK Historic Review for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 85: UK 16-Year Perspective for GABA Supplements by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 86: Spain Recent Past, Current & Future Analysis for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 88: Spain 16-Year Perspective for GABA Supplements by Form - Percentage Breakdown of Value Sales for Capsules Form, Lozenges Form, Powder Form and Gummies Form for the Years 2014, 2025 & 2030
    • TABLE 89: Spain Recent Past, Current & Future Analysis for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Spain Historic Review for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 91: Spain 16-Year Perspective for GABA Supplements by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 92: Russia Recent Past, Current & Future Analysis for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 94: Russia 16-Year Perspective for GABA Supplements by Form - Percentage Breakdown of Value Sales for Capsules Form, Lozenges Form, Powder Form and Gummies Form for the Years 2014, 2025 & 2030
    • TABLE 95: Russia Recent Past, Current & Future Analysis for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Russia Historic Review for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 97: Russia 16-Year Perspective for GABA Supplements by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 100: Rest of Europe 16-Year Perspective for GABA Supplements by Form - Percentage Breakdown of Value Sales for Capsules Form, Lozenges Form, Powder Form and Gummies Form for the Years 2014, 2025 & 2030
    • TABLE 101: Rest of Europe Recent Past, Current & Future Analysis for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Rest of Europe Historic Review for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 103: Rest of Europe 16-Year Perspective for GABA Supplements by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • GABA Supplements Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for GABA Supplements by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for GABA Supplements by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 16-Year Perspective for GABA Supplements by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 109: Asia-Pacific 16-Year Perspective for GABA Supplements by Form - Percentage Breakdown of Value Sales for Capsules Form, Lozenges Form, Powder Form and Gummies Form for the Years 2014, 2025 & 2030
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific Historic Review for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 112: Asia-Pacific 16-Year Perspective for GABA Supplements by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • GABA Supplements Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 113: Australia Recent Past, Current & Future Analysis for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 115: Australia 16-Year Perspective for GABA Supplements by Form - Percentage Breakdown of Value Sales for Capsules Form, Lozenges Form, Powder Form and Gummies Form for the Years 2014, 2025 & 2030
    • TABLE 116: Australia Recent Past, Current & Future Analysis for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Australia Historic Review for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 118: Australia 16-Year Perspective for GABA Supplements by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels for the Years 2014, 2025 & 2030
  • INDIA
    • GABA Supplements Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 119: India Recent Past, Current & Future Analysis for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 120: India Historic Review for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 121: India 16-Year Perspective for GABA Supplements by Form - Percentage Breakdown of Value Sales for Capsules Form, Lozenges Form, Powder Form and Gummies Form for the Years 2014, 2025 & 2030
    • TABLE 122: India Recent Past, Current & Future Analysis for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 123: India Historic Review for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 124: India 16-Year Perspective for GABA Supplements by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 127: South Korea 16-Year Perspective for GABA Supplements by Form - Percentage Breakdown of Value Sales for Capsules Form, Lozenges Form, Powder Form and Gummies Form for the Years 2014, 2025 & 2030
    • TABLE 128: South Korea Recent Past, Current & Future Analysis for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 129: South Korea Historic Review for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 130: South Korea 16-Year Perspective for GABA Supplements by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 16-Year Perspective for GABA Supplements by Form - Percentage Breakdown of Value Sales for Capsules Form, Lozenges Form, Powder Form and Gummies Form for the Years 2014, 2025 & 2030
    • TABLE 134: Rest of Asia-Pacific Recent Past, Current & Future Analysis for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of Asia-Pacific Historic Review for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 136: Rest of Asia-Pacific 16-Year Perspective for GABA Supplements by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • GABA Supplements Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for GABA Supplements by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for GABA Supplements by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 139: Latin America 16-Year Perspective for GABA Supplements by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 142: Latin America 16-Year Perspective for GABA Supplements by Form - Percentage Breakdown of Value Sales for Capsules Form, Lozenges Form, Powder Form and Gummies Form for the Years 2014, 2025 & 2030
    • TABLE 143: Latin America Recent Past, Current & Future Analysis for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Latin America Historic Review for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 145: Latin America 16-Year Perspective for GABA Supplements by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 148: Argentina 16-Year Perspective for GABA Supplements by Form - Percentage Breakdown of Value Sales for Capsules Form, Lozenges Form, Powder Form and Gummies Form for the Years 2014, 2025 & 2030
    • TABLE 149: Argentina Recent Past, Current & Future Analysis for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Argentina Historic Review for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 151: Argentina 16-Year Perspective for GABA Supplements by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 154: Brazil 16-Year Perspective for GABA Supplements by Form - Percentage Breakdown of Value Sales for Capsules Form, Lozenges Form, Powder Form and Gummies Form for the Years 2014, 2025 & 2030
    • TABLE 155: Brazil Recent Past, Current & Future Analysis for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Brazil Historic Review for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 157: Brazil 16-Year Perspective for GABA Supplements by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 160: Mexico 16-Year Perspective for GABA Supplements by Form - Percentage Breakdown of Value Sales for Capsules Form, Lozenges Form, Powder Form and Gummies Form for the Years 2014, 2025 & 2030
    • TABLE 161: Mexico Recent Past, Current & Future Analysis for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Mexico Historic Review for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 163: Mexico 16-Year Perspective for GABA Supplements by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 166: Rest of Latin America 16-Year Perspective for GABA Supplements by Form - Percentage Breakdown of Value Sales for Capsules Form, Lozenges Form, Powder Form and Gummies Form for the Years 2014, 2025 & 2030
    • TABLE 167: Rest of Latin America Recent Past, Current & Future Analysis for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Rest of Latin America Historic Review for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 169: Rest of Latin America 16-Year Perspective for GABA Supplements by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • GABA Supplements Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for GABA Supplements by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for GABA Supplements by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 172: Middle East 16-Year Perspective for GABA Supplements by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 175: Middle East 16-Year Perspective for GABA Supplements by Form - Percentage Breakdown of Value Sales for Capsules Form, Lozenges Form, Powder Form and Gummies Form for the Years 2014, 2025 & 2030
    • TABLE 176: Middle East Recent Past, Current & Future Analysis for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Middle East Historic Review for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 178: Middle East 16-Year Perspective for GABA Supplements by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 179: Iran Recent Past, Current & Future Analysis for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 181: Iran 16-Year Perspective for GABA Supplements by Form - Percentage Breakdown of Value Sales for Capsules Form, Lozenges Form, Powder Form and Gummies Form for the Years 2014, 2025 & 2030
    • TABLE 182: Iran Recent Past, Current & Future Analysis for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Iran Historic Review for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 184: Iran 16-Year Perspective for GABA Supplements by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 185: Israel Recent Past, Current & Future Analysis for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 187: Israel 16-Year Perspective for GABA Supplements by Form - Percentage Breakdown of Value Sales for Capsules Form, Lozenges Form, Powder Form and Gummies Form for the Years 2014, 2025 & 2030
    • TABLE 188: Israel Recent Past, Current & Future Analysis for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Israel Historic Review for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 190: Israel 16-Year Perspective for GABA Supplements by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 193: Saudi Arabia 16-Year Perspective for GABA Supplements by Form - Percentage Breakdown of Value Sales for Capsules Form, Lozenges Form, Powder Form and Gummies Form for the Years 2014, 2025 & 2030
    • TABLE 194: Saudi Arabia Recent Past, Current & Future Analysis for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Saudi Arabia Historic Review for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 196: Saudi Arabia 16-Year Perspective for GABA Supplements by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 197: UAE Recent Past, Current & Future Analysis for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 199: UAE 16-Year Perspective for GABA Supplements by Form - Percentage Breakdown of Value Sales for Capsules Form, Lozenges Form, Powder Form and Gummies Form for the Years 2014, 2025 & 2030
    • TABLE 200: UAE Recent Past, Current & Future Analysis for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 201: UAE Historic Review for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 202: UAE 16-Year Perspective for GABA Supplements by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 205: Rest of Middle East 16-Year Perspective for GABA Supplements by Form - Percentage Breakdown of Value Sales for Capsules Form, Lozenges Form, Powder Form and Gummies Form for the Years 2014, 2025 & 2030
    • TABLE 206: Rest of Middle East Recent Past, Current & Future Analysis for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Rest of Middle East Historic Review for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 208: Rest of Middle East 16-Year Perspective for GABA Supplements by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels for the Years 2014, 2025 & 2030
  • AFRICA
    • GABA Supplements Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 209: Africa Recent Past, Current & Future Analysis for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 211: Africa 16-Year Perspective for GABA Supplements by Form - Percentage Breakdown of Value Sales for Capsules Form, Lozenges Form, Powder Form and Gummies Form for the Years 2014, 2025 & 2030
    • TABLE 212: Africa Recent Past, Current & Future Analysis for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Africa Historic Review for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 214: Africa 16-Year Perspective for GABA Supplements by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels for the Years 2014, 2025 & 2030

IV. COMPETITION